Genetic variation of 3β-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: Implications for prostate cancer risk

Prostate

Volumn 33, Issue 1, 1997, Pages 9-12

  Devgan, Sunita A ^a   Henderson, Brian E ^a   Yu, Mimi C ^a   Shi, Chen Yang ^b   Pike, Malcolm C ^a   Ross, Ronald K ^a   Reichardt, Juergen K V ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Androgen metabolism; Complex dinucleotide repeat polymorphism; PCR; Racial ethnic variation of prostate cancer risk

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROSTANOLONE;

ANDROGEN METABOLISM; ARTICLE; CANCER RISK; ETHNIC GROUP; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE SECRETION;

3-HYDROXYSTEROID DEHYDROGENASES; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CONTINENTAL POPULATION GROUPS; DINUCLEOTIDE REPEATS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ISOENZYMES; MALE; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RISK FACTORS; VARIATION (GENETICS);

EID: 0030801333     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970915)33:1<9::AID-PROS2>3.0.CO;2-H     Document Type: Article

References (15)

1. American Cancer Society: "Cancer Facts and Figures." New York: American Cancer Society, 1994.
2. Bernstein L, Ross RK: "Cancer in Los Angeles County: A Portrait of Incidence and Mortality." Los Angeles: University of Southern California, 1991, pp 56-57.
3. Ross RK, Bernstein L, Lobo RA, Shimizu H, Stanczyck FZ, Pike MC, Henderson BE: 5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 339:887-889, 1992.
4. Nature Genetics Editorial: The prognosis for prostate cancer. Nature Genet 6:215-216, 1994.
5. Cannon-Albright L, Eeles R: Progress in prostate cancer. Nature Genet 9:336-338, 1995.
6. Coffey DS: The molecular biology of the prostate. In Lepor H, Lawson RK (eds): "Prostate Diseases." Philadelphia: W.B. Saunders, pp 28-56.
7. Labrie F, Simard J, Luu-The V, Belanger A, Pelletier G: Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine and steroidogenic tissue. J Steroid Biochem Mol Biol 43:805-826, 1992.
8. Berube D, Luu-The V, Lachance Y, Gagne R, Labrie F: Assignment of the human 3β-hydroxysteroid dehydrogenase gene to the p13 band of chromosome 1. Cytogenet Cell Genet 52:199-200, 1989.
9. Rheaume E, Simard J, Morel Y, Mebarki F, Zachman M, Forest MG, New MI, Labrie F: Congenital adrenal hyperplasia due to point mutations in the type II of 3β-hydroxysteroid dehydrogenase gene. Nature Genet 1:239-245, 1992.
10. Verreault H, Dufort I, Simard J, Labrie F, Luu-The V: Dinucleotide repeat polymorphisms in the HSD3B2 gene. Hum Mol Genet 3:384, 1994.
11. Reichardt JKV, Makridakis N, Henderson BE, Yu MC, Pike MC, Ross RK: Genetic variability of the human SRD5A2 gene: Implications for prostate cancer risk. Cancer Res 55:3973-3975, 1995.
12. Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK, Henderson BE: Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nature Med 1:827-829, 1995.
13. Sambrook J, Fritsch EF, Maniatis T: "Molecular Cloning," 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
14. Mehta CR, Patel NR: A network algorithm for performing Fischer's exact test in RxC contingency tables. J Am Stat Assoc 78: 427-434, 1983.
15. EPILOG, Epicenter Software, Pasadena, CA.